» Articles » PMID: 26558092

The Pathophysiology of Peyronie's Disease

Overview
Journal Arab J Urol
Date 2015 Nov 12
PMID 26558092
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To review the contemporary knowledge of the pathophysiology of Peyronie's disease (PD).

Methods: Medline was searched for papers published in English from 2000 to March 2013, using the keywords 'Peyronie's disease' and 'pathophysiology'.

Results: More than 300 relevant articles were identified for the purpose of this review. Unfortunately only a few studies had a high level of evidence, and the remaining studies were not controlled in their design. Many theories have been proposed to explain the cause of PD, but the true pathogenesis of PD remains an enigma. Identifying particular growth factors and the specific genes responsible for the induction of PD have been the ultimate goal of research over the past several decades. This would provide the means to devise a possible gene therapy for this devastating condition. We discuss present controversies and new discoveries related to the pathophysiology of this condition.

Conclusion: PD is one of the most puzzling diseases in urology. The pathogenesis remains uncertain and there is still controversy about the best management. The pathogenesis of PD has been explored in animal models, cell cultures and clinical trials, but the results have led to further questions. New research on the aetiology and pathogenesis of PD is needed, and which will hopefully improve the understanding and management for patients with this frustrating disease.

Citing Articles

Oxidative Mechanism of Peyronie's Disease and Effectiveness of Pentoxifylline in the Therapeutic Management: A Narrative Review.

Paulis G, Paulis A Antioxidants (Basel). 2025; 14(2).

PMID: 40002394 PMC: 11851550. DOI: 10.3390/antiox14020208.


Treatment with Autologous Adipose-derived Regenerative Cells for Peyronie's Disease in Men: The Straight @head Pilot Study.

Wiborg M, Kroijer R, Laursen B, Chakari W, Jensen C, Sorensen J Eur Urol Open Sci. 2025; 71():180-186.

PMID: 39845743 PMC: 11751568. DOI: 10.1016/j.euros.2024.12.005.


Outcomes of surgical correction of Peyronie's disease with plaque excision and grafting: Comparison of testicular tunica vaginalis graft versus bovine pericardium graft.

Eslahi A, Ahmed F, Askarpour M, Nikbakht H, Shamohammadi I, Ghasemi P Asian J Urol. 2024; 11(3):497-503.

PMID: 39220831 PMC: 11364893. DOI: 10.1016/j.ajur.2023.03.005.


Clinical Presentation of Peyronie's Disease: A Retrospective Study of 564 Cases.

Paulis G, De Giorgio G, Paulis A Diagnostics (Basel). 2024; 14(11).

PMID: 38893650 PMC: 11172383. DOI: 10.3390/diagnostics14111125.


Ultrasound Elastography as a Diagnostic Tool for Peyronie's Disease: A State-of-the-Art Review.

Paulis G, De Giorgio G, Paulis A Diagnostics (Basel). 2024; 14(6).

PMID: 38535085 PMC: 10969672. DOI: 10.3390/diagnostics14060665.


References
1.
Poli G, Parola M . Oxidative damage and fibrogenesis. Free Radic Biol Med. 1997; 22(1-2):287-305. DOI: 10.1016/s0891-5849(96)00327-9. View

2.
El-Sakka A, Hassan M, Nunes L, Bhatnagar R, Yen T, Lue T . Histological and ultrastructural alterations in an animal model of Peyronie's disease. Br J Urol. 1998; 81(3):445-52. DOI: 10.1046/j.1464-410x.1998.00529.x. View

3.
Bivalacqua T, Diner E, Novak T, Vohra Y, Sikka S, Champion H . A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol. 2000; 163(6):1992-8. View

4.
El-Sakka A, Tayeb K . Peyronie's disease in diabetic patients being screened for erectile dysfunction. J Urol. 2005; 174(3):1026-30. DOI: 10.1097/01.ju.0000170231.51306.32. View

5.
Gonzalez-Cadavid N, Rajfer J . Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease. Nat Clin Pract Urol. 2006; 2(6):291-7. DOI: 10.1038/ncpuro0201. View